3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Immunoglobulin Light-chain Amyloidosis
3
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Amyloidosis
1
Amyloid Neuropathies, Familial
1
Interventions
Curcumin
3
piperine
1
Urination
1
Tissue Banks
1
Probiotics
1
Metformin
1
Docosahexaenoic Acids
1
Diet, Plant-Based
1
Diet, Mediterranean
1
Blood Specimen Collection
1
Biopsy
1
Absorptiometry, Photon
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
1 year
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled